08th week of 2017 patent applcation highlights part 8 |
Patent application number | Title | Published |
20170049739 | PROSTACYCLIN COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | 2017-02-23 |
20170049740 | USE OF HISTONE DEACETYLASE INHIBITORS FOR THE CARE OF PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE SYNDROMES | 2017-02-23 |
20170049741 | Formulations for Cathepsin K Inhibitors | 2017-02-23 |
20170049742 | Method for treating a glycoprotein-related disease | 2017-02-23 |
20170049743 | Methods Of Using Low-Dose Doxepin For The Improvement Of Sleep | 2017-02-23 |
20170049744 | PREVENTION OR TREATMENT AGENT FOR CEREBRAL AMYLOID BETA STORAGE DISEASES | 2017-02-23 |
20170049745 | METHODS AND COMPOSITIONS FOR TARGETING CANCER STEM CELLS | 2017-02-23 |
20170049746 | USES OF BUTYLIDENEPHTHALIDE | 2017-02-23 |
20170049747 | METHODS TO MOBILIZE PROGENITOR/STEM CELLS | 2017-02-23 |
20170049748 | METHODS AND COMPOSITIONS FOR ENHANCED TRANSUNGUAL DELIVERY OF AR-12 | 2017-02-23 |
20170049749 | METHODS FOR TREATING BURNS USING ALLANTOIN | 2017-02-23 |
20170049750 | Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents | 2017-02-23 |
20170049751 | OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF | 2017-02-23 |
20170049752 | METHODS FOR DOSING AN ORALLY ACTIVE 1,2,4-OXADIAZOLE FOR NONSENSE MUTATION SUPPRESSION THERAPY | 2017-02-23 |
20170049753 | METHODS AND COMPOSITIONS FOR INCREASING FERTILITY AND/OR INHIBITING PREGNANCY FAILURE AND RESTORING GLUCOSE TOLERANCE | 2017-02-23 |
20170049754 | PHARMACEUTICAL COMPOSITIONS COMPRISING 40 - O - ( 2 - HYDROXY) ETHYL - RAPAMYCIN | 2017-02-23 |
20170049755 | HISTONE DEACETYLASE AS A MODULATOR OF PDL1 EXPRESSION AND ACTIVITY | 2017-02-23 |
20170049756 | COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS | 2017-02-23 |
20170049757 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF ANXIETY AND PANIC USING BETA ADRENERGIC RECEPTOR ANTAGONIST AND MUSCARINIC RECEPTOR ANTAGONIST COMBINATIONS | 2017-02-23 |
20170049758 | LIQUID FORMULATIONS CONTAINING PICOSULFATE AND MAGNESIUM CITRATE | 2017-02-23 |
20170049759 | TRANSDERMAL AND/OR TOPICAL DELIVERY SYSTEMS COMPOSED OF DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE IN COMBINATION, OR ALONE | 2017-02-23 |
20170049760 | INHIBITORS OF RHO ASSOCIATED PROTEIN KINASES (ROCK) AND METHODS OF USE | 2017-02-23 |
20170049761 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF JUVENILE NEURONAL CEROID LIPOFUSCINOSIS AND RELATED DISORDERS | 2017-02-23 |
20170049762 | 5-DEUTERO-2,4-THIAZOLIDINEDIONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | 2017-02-23 |
20170049763 | NOVEL OXAZOLIDINONE DERIVATIVES | 2017-02-23 |
20170049764 | Dosing Preparation of Dabigatran Etexilate or a Salt Thereof and a Preparation Method Thereof | 2017-02-23 |
20170049765 | Methylphenidate-Prodrugs, Processes of Making and Using the Same | 2017-02-23 |
20170049766 | METHOD AND DOSE FOR THE ADMINISTRATION OF DEXMEDETOMIDINE, FENTANYL AND PROPOFOL FOR CONSCIOUS SEDATION IN SURGERY | 2017-02-23 |
20170049767 | COMBINATION THERAPY FOR CANCER TREATMENT | 2017-02-23 |
20170049768 | METHODS FOR TREATING PANCREATIC CANCER USING COMBINATION THERAPIES | 2017-02-23 |
20170049769 | Abuse Deterrent Compositions and Methods of Making Same | 2017-02-23 |
20170049770 | PRODUCT AND METHOD FOR TREATING DIARRHEA | 2017-02-23 |
20170049771 | TARGETING PARP1 FOR TREATMENT OF TSC AND CANCERS | 2017-02-23 |
20170049772 | INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA | 2017-02-23 |
20170049773 | PHARMACEUTICAL COMPOSITION CONTAINING GPR119 LIGAND AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING NON-ALCOHOLIC FATTY LIVER DISEASE | 2017-02-23 |
20170049774 | SUSTAINED RELEASE ORAL PHARMACEUTICAL COMPOSITIONS OF TOFACITINIB | 2017-02-23 |
20170049775 | Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin | 2017-02-23 |
20170049776 | Sildenafil Solutions and Methods of Making and Using Same | 2017-02-23 |
20170049777 | COMPOSITIONS, METHODS AND USES FOR THE TREATMENT OF DIABETIC NEUROPATHIES | 2017-02-23 |
20170049779 | FLAGELLAR AND NEEDLE COMPLEX (INJECTOSOME) LOOP AS ANTI BACTERIAL DRUG TARGET | 2017-02-23 |
20170049780 | USE OF (2R, 6R)-HYDROXYNORKETAMINE, (S)-DEHYDRONORKETAMINE AND OTHER STEREOISOMERIC DEHYDRO AND HYDROXYLATED METABOLITES OF (R,S)- KETAMINE IN THE TREATMENT OF DEPRESSION AND NEUROPATHIC PAIN | 2017-02-23 |
20170049781 | HSP90 INHIBITOR COMBINATIONS | 2017-02-23 |
20170049782 | ACTIVE INGREDIENT (I) CONTAINING COMPOSITION AND METHOD FOR PREPARING SAME | 2017-02-23 |
20170049783 | METHODS OF TREATING DISORDERS ASSOCIATED WITH PROTEIN POLYMERIZATION | 2017-02-23 |
20170049784 | METHOD OF TREATING ACUTE MYELOID LEUKEMIA AND/OR ACUTE LYMPHOBLASTIC LEUKEMIA USING THIENOTRIAZOLODIAZEPINE COMPOUNDS | 2017-02-23 |
20170049785 | ESTROGEN COMBINATION FOR TREATMENT OF MULTIPLE SCLEROSIS | 2017-02-23 |
20170049786 | MTOR PATHWAY INHIBITORS FOR TREATING OCULAR DISORDERS | 2017-02-23 |
20170049787 | Derivatives of Ergostatrien-3-Beta-OL From Antrodia Camphorata and Antiglycemic, Antihyperlipidemic and Decreasing Hepatic Fat Use Thereof | 2017-02-23 |
20170049788 | Abiraterone Steroid Formulation | 2017-02-23 |
20170049789 | TOPICAL FILM DELIVERY SYSTEM | 2017-02-23 |
20170049790 | COMBINATION THERAPIES TARGETING MITOCHONDRIA FOR CANCER THERAPY | 2017-02-23 |
20170049791 | COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING COMPLEX REGIONAL PAIN SYNDROME | 2017-02-23 |
20170049792 | USE OF GINSENOSIDE M1 FOR TREATING LUPUS NEPHRITIS | 2017-02-23 |
20170049793 | MOLECULAR ACTIVATORS OF THE WNT/BETA-CATENIN PATHWAY | 2017-02-23 |
20170049794 | PDIA4 PROTEIN AS A TARGET FOR DIAGNOSIS, MONITORING AND TREATMENT OF DIABETES | 2017-02-23 |
20170049795 | Composition and Methods Of Treating Acne And Photoaging | 2017-02-23 |
20170049796 | ADMINISTRATION OF CITICOLINE TO IMPROVE COGNITIVE PERFORMANCE, ATTENTIONAL PERFORMANCE, AND MOTOR FUNCTION | 2017-02-23 |
20170049797 | COMBINATION THERAPY FOR TREATING HCV INFECTION | 2017-02-23 |
20170049798 | Maintenance of Platelet Inhibition During Antiplatelet Therapy | 2017-02-23 |
20170049799 | OPHTHALMIC FORMULATIONS | 2017-02-23 |
20170049800 | PHARMACEUTICAL COMBINATION COMPRISING A CIP2A SILENCING AGENT FOR USE IN THE TREATMENT OF A HYPERPROLIFERATIVE DISORDER, PREFERABLY ONE WITH IMPAIRED P53 FUNCTION | 2017-02-23 |
20170049801 | MULTIBLOCK COPOLYMERS | 2017-02-23 |
20170049802 | METHODS AND COMPOSITIONS FOR TREATING ROSACEA | 2017-02-23 |
20170049803 | Glycosaminoglycan Composition and Method of Use for Kidney Stone Removal | 2017-02-23 |
20170049804 | FAST ACTING JOINT RELIEF FORMULATIONS | 2017-02-23 |
20170049805 | PROCESS FOR SUSTAINED NEUROMODULATION OF THE NERVOUS SYSTEM | 2017-02-23 |
20170049806 | GRANULAR COMPOSITION FOR ORAL ADMINISTRATION | 2017-02-23 |
20170049807 | STRONTIUM BASED COMPOSITIONS AND FORMULATIONS FOR PAIN, PRURITUS, AND INFLAMMATION | 2017-02-23 |
20170049808 | Calcium Formate for Use as a Dietary Supplement | 2017-02-23 |
20170049809 | COMPOSITIONS AND METHODS TO MODULATE ANGIOGENESIS | 2017-02-23 |
20170049810 | TREATMENT AND PREVENTION OF ALZHEIMER'S DISEASE (AD) | 2017-02-23 |
20170049811 | MODIFIED SINGLE DOSE, MICROPLEGIC APPROACH TO CARDIOPLEGIA FOR ADULT HEART | 2017-02-23 |
20170049812 | TREATMENT AND PREVENTION OF ALZHEIMER'S DISEASE (AD) | 2017-02-23 |
20170049813 | ANTIMICROBIAL SOLUTIONS CONTAINING DICHLORINE MONOXIDE AND METHODS OF MAKING AND USING THE SAME | 2017-02-23 |
20170049814 | Suspension of Graphene Oxide Nanoflakes in Water, Its Use and a Method of Preparation Thereof | 2017-02-23 |
20170049815 | Selective Chemotherapy Treatments and Diagnostic Methods Related Thereto | 2017-02-23 |
20170049816 | Methods of Benchmarking Wellness with a Stable Reactive Oxygen Species Solution | 2017-02-23 |
20170049817 | METHODS AND SYSTEMS FOR PROCESSING EXOSOMES | 2017-02-23 |
20170049818 | METHODS FOR OFF-THE-SHELF-TUMOR IMMUNOTHERAPY USING ALLOGENEIC T-CELL PRECURSORS | 2017-02-23 |
20170049819 | KAPPA/LAMBDA CHIMERIC ANTIGEN RECEPTORS | 2017-02-23 |
20170049820 | ENHANCED STEM CELL COMPOSITION | 2017-02-23 |
20170049821 | ENCAPSULATED MESENCHYMAL STEM CELLS AND USES THEREOF | 2017-02-23 |
20170049822 | METHODS OF ENHANCING STEM CELL ENGRAFTMENT | 2017-02-23 |
20170049823 | PHARMACEUTICAL COMPOSITION INCLUDING THREE-DIMENSIONAL CELL CLUSTER AND ANGIOPOIETIN FOR PREVENTING AND TREATING ISCHEMIC DISEASE | 2017-02-23 |
20170049824 | METHODS FOR IMPROVING HEALTH OF FARMED FISH | 2017-02-23 |
20170049825 | IMMUNOSTIMULATORY COMPOSITIONS AND METHODS OF USE THEREOF | 2017-02-23 |
20170049826 | MICROBIOTA RESTORATION THERAPY (MRT), COMPOSITIONS AND METHODS OF MANUFACTURE | 2017-02-23 |
20170049827 | MICROBIOTA RESTORATION THERAPY (MRT), COMPOSITIONS AND METHODS OF MANUFACTURE | 2017-02-23 |
20170049828 | LACTIC ACID BACTERIA CAPABLE OF PREVENTING AND/OR TREATING SENESCENCE AND DEMENTIA | 2017-02-23 |
20170049829 | ATTENUATED REOVIRUS | 2017-02-23 |
20170049830 | PURIFIED CANNABINOID PRODUCT AND SYSTEM AND METHOD FOR PRODUCING THE SAME | 2017-02-23 |
20170049831 | ORAL COMPOSITIONS AND ROUTE OF ADMINISTRATION FOR THE DELIVERY OF A THYLAKOID EXTRACT | 2017-02-23 |
20170049832 | COMPOSITION COMPRISING DENDROPANAX MORBIFERA EXTRACT | 2017-02-23 |
20170049833 | INHIBITOR OF INFLAMMATORY CONDITIONS | 2017-02-23 |
20170049834 | BENIGN PROSTATIC HYPERPLASIA ADD-ON THERAPY | 2017-02-23 |
20170049835 | Herbal Combinations For Treating Scalp Conditions | 2017-02-23 |
20170049836 | COMPOSITIONS COMPRISING BOTANICALS, INCLUDING THE USE AND METHOD OF USE THEREOF | 2017-02-23 |
20170049837 | METHOD OF TREATING INFLAMMATION, ALLERGY AND ASTHMA WITH A PURIFIED EXTRACT (ATC2) ISOLATED FROM PSEUDOLYSIMACHION ROTUNDUM VAR. SUBINTEGRUM CONTAINING ABUNDANT AMOUNT OF ACTIVE INGREDIENT | 2017-02-23 |
20170049838 | METHOD OF TREATING INFLAMMATION, ALLERGY AND ASTHMA WITH A PURIFIED EXTRACT (ATC1) ISOLATED FROM PSEUDOLYSIMACHION ROTUNDUM VAR. SUBINTEGRUM CONTAINING ABUNDANT AMOUNT OF ACTIVE INGREDIENT | 2017-02-23 |
20170049839 | Therapeutic molecules & deviates for CRC | 2017-02-23 |